Partner With Us
At RevOpsis, we are focused on enabling the development of our proprietary Rev-Mod Platform across a broad range of therapeutic areas in collaboration with capable leaders in the industry. Partnerships and licensing are a key part of our commitment to address unmet needs for patients worldwide.
The Rev-Mod Platform uses a fully human modular system to generate proprietary multispecific biologic solutions. We are actively seeking partners to increase the impact of our technology in the numerous races against challenging multifactorial diseases.
The Rev-Mod Platform is exclusive to RevOpsis Therapeutics with granted patents that provide strong global IP support to readily generate proprietary therapeutics in any of our Multi-Mod biologic formats.
Come Mod with Us!